Common use of Implementation Report Clause in Contracts

Implementation Report. Within 150 days after the Effective Date, CHSI shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. The name, address, phone number, and position description of the Corporate Compliance and Privacy Officer required by Section III.A.1, and a summary of other noncompliance job responsibilities the Corporate Compliance and Privacy Officer may have; Community Health Systems, Inc. Corporate Integrity Agreement, Amended 2. the name, address, phone number, and position description of each Senior Compliance Director, Corporate Compliance Director, and Facility Compliance Officers required by Section III.A.2, and a summary of other noncompliance job responsibilities each Senior Compliance Director, Corporate Compliance Director, and Facility Compliance officers may have; 3. the names and positions of the members of the Corporate Compliance Work Group required by Section III.A.3; 4. the names and positions of the members of each Facility Compliance Committee required by Section III.A.4; 5. the names of the Board members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.5; 6. a copy of CHSI’s Code of Conduct required by Section III.B.1; 7. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request); 8. a summary of all Policies and Procedures required by Section III.B.2 (copies of the Policies and Procedures shall be made available to OIG upon request); 9. the following information regarding each type of training required by Section III.C: a. a description of such training, including a summary of the topics covered, the length of sessions, and a schedule of training sessions; b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions; and c. with respect to active medical staff members, the number and percentage who completed the training, the type of training Community Health Systems, Inc. Corporate Integrity Agreement, Amended and the date received, and a description of CHSI’s efforts to encourage medical staff members to complete the training. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request. 10. a description of (a) the Focus Arrangements Tracking System required by Section III.D.1.a, (b) the internal review and approval process required by Section III.D.1.e; and (c) the tracking and monitoring procedures and other Focus Arrangements Procedures required by Section III.D.1; 11. a description of the Disclosure Program required by Section III.F;

Implementation Report. Within 150 days after the Effective Date, CHSI Walgreens shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. The the name, address, phone number, and position description of the Corporate Compliance and Privacy Ethics Officer required by Section III.A.1III.A, and a summary of other noncompliance job responsibilities the Corporate Compliance and Privacy Ethics Officer may have; Community Health Systems, Inc. Corporate Integrity Agreement, Amended 2. the name, address, phone number, and position description of each Senior Compliance Director, Corporate Compliance Director, and Facility Compliance Officers required by Section III.A.2, and a summary of other noncompliance job responsibilities each Senior Compliance Director, Corporate Compliance Director, and Facility Compliance officers may have; 32. the names and positions of the members of the Corporate Compliance Work Group required by Section III.A.3; 4. the names and positions of the members of each Facility Compliance Committee required by Section III.A.4III.A; 53. the names of the Audit Committee of the Board members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.5III.A.3; 64. the names and positions of the Certifying Employees required by Section III.A.4, and a copy of CHSI’s Code of Conduct required by Section III.B.1; 7. the number of individuals required to complete written process for completing the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request)III.A.4; 85. a summary list of all the Policies and Procedures required by Section III.B.2 (copies of the Policies and Procedures shall be made available to OIG upon request);III.B; Walgreen Co. - Corporate Integrity Agreement 96. the following information regarding each type of training Training Plan required by Section III.C: a. III.C.1 and a description of such training, the Board Member Training required by Section III.C.2 (including a summary of the topics covered, the length of sessionsthe training, and a schedule of when the training sessionswas provided); b. 7. the number of individuals required to be trainedfollowing information regarding the IRO(s): (a) identity, percentage of individuals actually trainedaddress, and an explanation phone number; (b) a copy of any exceptionsthe engagement letter; and c. (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A to this CIA; and (d) a certification from the IRO regarding its professional independence and objectivity with respect to active medical staff members, the number and percentage who completed the training, the type of training Community Health Systems, Inc. Corporate Integrity Agreement, Amended and the date received, and a description of CHSI’s efforts to encourage medical staff members to complete the training. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request.Walgreens; 108. a description of (a) the Focus Arrangements Tracking System required by Section III.D.1.a, (b) the risk assessment and internal review and approval process required by Section III.D.1.eIII.E; and (c) the tracking and monitoring procedures and other Focus Arrangements Procedures required by Section III.D.1; 119. a description of the Disclosure Program required by Section III.F; 10. a description of the Ineligible Persons screening and removal process required by Section III.G; 11. a copy of Walgreens’ policies and procedures regarding the identification, quantification and repayment of Overpayments required by Section III.I; 12. a description of Walgreens’ corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; 13. a list of all of Walgreens’ locations that perform Covered Functions (including locations and mailing addresses), the corresponding name under which each location is doing business, and the location’s Medicare and state Medicaid program provider number and/or supplier number(s); and

Implementation Report. Within 150 days after the Effective Date, CHSI IHS shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. The the name, address, phone number, and position description of the Corporate Compliance and Privacy Officer required by Section III.A.1, and a summary of other noncompliance job responsibilities the Corporate Compliance and Privacy Officer may have; Community Health Systems, Inc. Corporate Integrity Agreement, Amended 2. the name, address, phone number, and position description of each Senior Compliance Director, Corporate Compliance Director, and Facility Compliance Officers required by Section III.A.2, and a summary of other noncompliance job responsibilities each Senior Compliance Director, Corporate Compliance Director, and Facility Compliance officers may have; 32. the names and positions of the members of the Corporate Compliance Work Group required by Section III.A.3; 4. the names and positions of the members of each Facility Compliance Committee required by Section III.A.4III.A.2; 53. the names of the Board members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.5III.A.3; 64. the names and positions of the Certifying Employees required by Section III.A.4; 5. a copy of CHSIIHS’s Code of Conduct required by Section III.B.1; 7. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request); 86. a summary of all Policies and Procedures required by Section III.B.2 (copies of the Policies and Procedures shall be made available to OIG upon request); 97. the following information regarding each type Training Plan for General and Arrangements Training required by Section III.C.1 and a description of the Board of Directors training required by Section III.C: a. a description of such training, including a summary of the topics covered, the length of sessions, and a schedule of training sessionsIII.C.2; b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions; and c. with respect to active medical staff members, the number and percentage who completed the training, the type of training Community Health Systems, Inc. Corporate Integrity Agreement, Amended and the date received, and a description of CHSI’s efforts to encourage medical staff members to complete the training. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request. 108. a description of of: (a) the Focus Arrangements Tracking System required by Section III.D.1.a, ; (b) the internal review and approval process required by Section III.D.1.e; and (c) the tracking and monitoring procedures and other Focus Arrangements Procedures required by Section III.D.1; 9. the following information regarding the Legal IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the Legal IRO has the qualifications outlined in Appendix A to this CIA; and (d) a certification from the Legal IRO that it does not have a prohibited relationship to IHS as set forth in Section III.E.4; 10. a description of the risk assessment and mitigation process required by Section III.F; 11. a description of the Disclosure Program required by Section III.FIII.G; 12. a certification that IHS has conducted the screening required by Section III.H regarding Ineligible Persons; 13. a copy of IHS’s policies and procedures regarding the identification, quantification, and repayment of Overpayments required by Section III.J; 14. a list of all of IHS’s locations subject to the CIA (including physical locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; each location’s Medicare and state Medicaid program provider number(s) and/or supplier number(s); and the name and address of each Medicare and state Medicaid program contractor to which IHS currently submits claims; 15. a description of IHS’s corporate structure, including identification of any owners, parent and sister companies, subsidiaries, and their respective lines of business; and

Implementation Report. Within 150 120 days after the Effective Date, CHSI HealthSouth shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. The the name, address, phone number, and position description of the Corporate Compliance and Privacy Officer required by Section III.A.1III.A, and a summary of other noncompliance job responsibilities the Corporate Compliance and Privacy Officer may have; Community Health Systems, Inc. Corporate Integrity Agreement, Amended 2. the name, address, phone number, and position description of each Senior Compliance Director, Corporate Compliance Director, and Facility Compliance Officers required by Section III.A.2, and a summary of other noncompliance job responsibilities each Senior Compliance Director, Corporate Compliance Director, and Facility Compliance officers may have; 32. the names and positions of the members of the Corporate Executive Compliance Work Group required by Section III.A.3; 4. Committee and the names and positions of the members of each Facility Board Compliance Committee required by Section III.A.4III.A; 5. the names of the Board members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.5; 63. a copy of CHSIHealthSouth’s Code of Conduct required by Section III.B.1; Corporate Integrity Agreement HealthSouth Corporation 4. a copy of all policies and procedures required by Sections III.B.3.a through III.B.3.e, and a summary of all other policies and procedures required by Section III.B; 75. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG OIG, upon request); 8. a summary of all Policies and Procedures required by Section III.B.2 (copies of the Policies and Procedures shall be made available to OIG upon request); 96. the following information regarding each type of training required by Section III.C: a. a description of such training, including a summary of the topics covered, the length of sessions, sessions and a schedule of training sessionsschedule; b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions; and c. with respect to active medical staff members, the number and percentage who completed the training, the type of training Community Health Systems, Inc. Corporate Integrity Agreement, Amended and the date received, and a description of CHSI’s efforts to encourage medical staff members to complete the training. A copy of all training materials and the documentation supporting this information shall be made available to OIG OIG, upon request. 10. a description of (a) the Focus Arrangements Tracking System required by Section III.D.1.a, (b) the internal review and approval process required by Section III.D.1.e; and (c) the tracking and monitoring procedures and other Focus Arrangements Procedures required by Section III.D.1; 117. a description of the Disclosure Program required by Section III.E; 8. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) a summary and description of any and all current and prior engagements and agreements between HealthSouth and the IRO; and (d) the proposed start and completion dates of the Cost Reporting Engagement, Unallowable Cost Review, and Billing Engagement during the first CIA year; 9. a certification from the IRO regarding its professional independence and/or objectivity with respect to HealthSouth; 10. a description of the process by which HealthSouth fulfills the requirements of Section III.F regarding Ineligible Persons; 11. the name, title, and responsibilities of any person who is determined to be an Ineligible Person under Section III.F; the actions taken in response to the screening and removal obligations set forth in Section III.F; and the actions taken to identify, quantify, and repay any overpayments to Federal health care programs relating to items or services furnished, ordered or prescribed by an Ineligible Person; 12. to the extent not already provided to OIG, a list of all of HealthSouth’s facilities furnishing items or services that may be reimbursed by Federal health care programs including the address of each facility, phone number, Corporate Integrity Agreement HealthSouth Corporation fax number, Medicare Provider number, provider identification number and/or supplier number, and the corresponding contractor’s name and address that issued each Medicare number; 13. to the extent not already provided to OIG, a description of HealthSouth’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and 14. the certifications required by Section V.C.

Implementation Report. Within 150 days after the Effective Date, CHSI Sandoz shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. The the name, address, phone number, and position description of the Corporate Compliance and Privacy Officer required by Section III.A.1, and a summary of other noncompliance job responsibilities the Corporate Compliance and Privacy Officer may have; Community Health Systems, Inc. Corporate Integrity Agreement, Amended 2. the name, address, phone number, and position description of each Senior Compliance Director, Corporate Compliance Director, and Facility Compliance Officers required by Section III.A.2, and a summary of other noncompliance job responsibilities each Senior Compliance Director, Corporate Compliance Director, and Facility Compliance officers may have; 32. the names and positions of the members of the Corporate Compliance Work Group required by Section III.A.3; 4. the names and positions of the members of each Facility Compliance Committee required by Section III.A.4III.A.2; 53. the names of the Board members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.5III.A.3; 64. a copy the names and positions of CHSI’s Code of Conduct the Certifying Employees required by Section III.B.1III.A.4 and a written copy of the process to be followed by Certifying Employees in connection with completing the required certifications; 7. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request); 85. a summary list of all the Policies and Procedures required by Section III.B.2 (copies III.B; 6. the Training Plan required by Section III.C.1 and a description of the Policies and Procedures shall be made available to OIG upon request); 9. the following information regarding each type Board of Directors training required by Section III.C: a. a description of such training, III.C.2 (including a summary of the topics covered, the length of sessions, the training and a schedule of when the training sessionswas provided); b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions; and c. with respect to active medical staff members, the number and percentage who completed the training, the type of training Community Health Systems, Inc. Corporate Integrity Agreement, Amended and the date received, and a description of CHSI’s efforts to encourage medical staff members to complete the training. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request. 107. a description of (a) the Focus Arrangements Tracking System required by Section III.D.1.a, (b) the risk assessment and internal review and approval process required by Section III.D.1.eIII.D; 8. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A; and (cd) a certification from the tracking IRO regarding its professional independence and monitoring procedures and other Focus Arrangements Procedures required by Section III.D.1objectivity with respect to Sandoz; 119. a description of the Disclosure Program required by Section III.F; 10. a description of the Ineligible Persons screening and removal process required by Section III.G.; 11. a list of all of Sandoz’s locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers, and the location’s Medicare and state Medicaid program provider and/or supplier numbers (if any); 12. a description of Xxxxxx’x corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and

Implementation Report. Within 150 days after the Effective Date, CHSI Amedisys shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report)CIA. The This Implementation Report shall, at a minimum, shall include: 1. The the name, address, phone number, and position description of the Corporate Compliance and Privacy Officer required by Section III.A.1III.A, and a summary of other noncompliance job responsibilities the Corporate Compliance and Privacy Officer may have; Community Health Systems, Inc. Corporate Integrity Agreement, Amended 2. the name, address, phone number, and position description of each Senior Compliance Director, Corporate Compliance Director, and Facility Compliance Officers required by Section III.A.2, and a summary of other noncompliance job responsibilities each Senior Compliance Director, Corporate Compliance Director, and Facility Compliance officers may have; 32. the names and positions of the members of the Corporate Compliance Work Group required by Section III.A.3; 4. the names and positions of the members of each Facility Compliance Committee required by Section III.A.4III.A; 5. the names of the Board members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.5; 63. a copy of CHSI’s Amedisys’ Code of Conduct required by Section III.B.1; 74. a copy of all Policies and Procedures required by Section III.B.2; 5. a copy of all training materials used for the number training required by Section III.C, a description of individuals such training, including a description of the targeted audiences, length of sessions, which sessions were mandatory and for whom, percentage of attendance, and a schedule of when the training sessions were held; 6. a certification by the Compliance Officer that: a. the Policies and Procedures required by Section III.B have been developed, are being implemented, and have been distributed to complete all appropriate Covered Persons; b. all Covered Persons have completed the Code of Conduct certification required by Section III.B.1, the percentage of individuals who ; and c. all Covered Persons have completed such certificationthe applicable training and executed the certification(s) required by Section III.C. Amedisys, Inc. and an explanation of any exceptions (the Amedisys Specialized Medical Services, Inc. Corporate Integrity Agreement 18 The documentation supporting this information certification shall be available to OIG upon request); 8. a summary of all Policies and Procedures required by Section III.B.2 (copies of the Policies and Procedures shall be made available to OIG upon request); 9. the following information regarding each type of training required by Section III.C: a. a description of such trainingOIG, including a summary of the topics covered, the length of sessions, and a schedule of training sessions; b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions; and c. with respect to active medical staff members, the number and percentage who completed the training, the type of training Community Health Systems, Inc. Corporate Integrity Agreement, Amended and the date received, and a description of CHSI’s efforts to encourage medical staff members to complete the training. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request. 10. a description of (a) the Focus Arrangements Tracking System required by Section III.D.1.a, (b) the internal review and approval process required by Section III.D.1.e; and (c) the tracking and monitoring procedures and other Focus Arrangements Procedures required by Section III.D.1; 117. a description of the Disclosure Program required by Section III.FIII.E; 8. the identity of the IRO(s), a summary/description of all engagements between Amedisys and the IRO, including, but not limited to, any outside financial audits or reimbursement consulting, and the proposed start and completion dates of the Claims Review, Unallowable Cost Review, or Systems Review; 9. a certification from the IRO regarding its professional independence and/or objectivity with respect to Amedisys; 10. a summary of personnel actions (other than hiring) taken pursuant to Section III.F.; 11. a list of all of Amedisys’ locations (including locations and mailing addresses), the corresponding name under which each location is doing business, the corresponding phone numbers and fax numbers, each location’s Medicare provider identification number(s), and the name and address of the Medicare contractor to which Amedisys currently submits claims; 12. a description of Amedisys’ corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and 13. the certification required by Section V.C.

Implementation Report. Within 150 120 days after the Effective Date, CHSI United Therapeutics shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. The the name, address, phone number, and position description of the Corporate Compliance and Privacy Officer required by Section III.A.1, and a summary of other noncompliance job responsibilities the Corporate Compliance and Privacy Officer may have; Community Health Systems, Inc. Corporate Integrity Agreement, Amended 2. the name, address, phone number, and position description of each Senior Compliance Director, Corporate Compliance Director, and Facility Compliance Officers required by Section III.A.2, and a summary of other noncompliance job responsibilities each Senior Compliance Director, Corporate Compliance Director, and Facility Compliance officers may have; 32. the names and positions of the members of the Corporate Compliance Work Group Committee required by Section III.A.2; 3. the names of the members of the Board of Directors who are responsible for satisfying the compliance obligations described in Section III.A.3; 4. the identity and credentials of the Compliance Expert required by Section III.A.3; 5. the names and positions of the members of each Facility Compliance Committee Certifying Employees required by Section III.A.4; 5. the names of the Board members who are responsible for satisfying the Board of Directors compliance obligations described in Section III.A.5; 6. a copy list of CHSI’s Code of Conduct required by Section III.B.1; 7. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request); 8. a summary of all Policies and Procedures required by Section III.B.2 (copies III.B.3; 7. the Training Plan required by Section III.C.1 and a description of the Policies and Procedures shall be made available to OIG upon request); 9. the following information regarding each type Board of Directors training required by Section III.C: a. a description of such training, III.C.2 (including a summary of the topics covered, the length of sessions, the training and a schedule of when the training sessionswas provided); b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions; and c. with respect to active medical staff members, the number and percentage who completed the training, the type of training Community Health Systems, Inc. Corporate Integrity Agreement, Amended and the date received, and a description of CHSI’s efforts to encourage medical staff members to complete the training. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request. 108. a description of (a) the Focus Arrangements Tracking System required by Section III.D.1.a, (b) the risk assessment and internal review and approval process required by Section III.D.1.eIII.D; 9. the following information regarding the IRO(s): (a) identity, address, and phone number; (b) a copy of the engagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A; and (cd) a certification from the tracking IRO regarding its professional independence and monitoring procedures and other Focus Arrangements Procedures required by Section III.D.1; 11objectivity with respect to United Therapeutics; 10. a description of the Disclosure Program required by Section III.F; 11. a description of the Ineligible Persons screening and removal process required by Section III.G.; 12. a list of all of United Therapeutics’ locations (including locations and mailing addresses); the corresponding name under which each location is doing business; the corresponding phone numbers and fax numbers; 13. a description of United Therapeutics’ corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and 14. the certifications required by Section V.C.

Implementation Report. Within 150 days after the Effective Date, CHSI Aegerion shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. The the name, address, phone number, and position description of the Corporate Compliance and Privacy Officer required by Section III.A.1, and a summary of other noncompliance job responsibilities the Corporate Compliance and Privacy Officer may have; Community Health Systems, Inc. Corporate Integrity Agreement, Amended 2. the name, address, phone number, and position description of each Senior Compliance Director, Corporate Compliance Director, and Facility Compliance Officers required by Section III.A.2, and a summary of other noncompliance job responsibilities each Senior Compliance Director, Corporate Compliance Director, and Facility Compliance officers may have; 32. the names and positions of the members of the Corporate Compliance Work Group required by Section III.A.3; 4. the names and positions of the members of each Facility Compliance Committee required by Section III.A.4III.A.2; 53. the names of the Board members who are responsible for satisfying the Board of Directors compliance obligations described referenced in Section III.A.5III.A.3; 64. a copy the names and positions of CHSI’s Code of Conduct the Certifying Employees required by Section III.B.1; 7. III.A.4 and a written copy of the number of individuals required process followed to complete the Code of Conduct certification required by requirements set forth in Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be available to OIG upon request)III.A.4; 85. a summary list of all Policies and Procedures required by Section III.B.2 (copies III.B; 6. the Training Plan required by Section III.C.1 and a description of the Policies and Procedures shall be made available to OIG upon request); 9. the following information regarding each type Board of Directors training required by Section III.C: a. a description of such training, III.C.2 (including a summary of the topics covered, the length of sessions, the training and a schedule of when the training sessionswas provided); b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions; and c. with respect to active medical staff members, the number and percentage who completed the training, the type of training Community Health Systems, Inc. Corporate Integrity Agreement, Amended and the date received, and a description of CHSI’s efforts to encourage medical staff members to complete the training. A copy of all training materials and the documentation supporting this information shall be made available to OIG upon request. 107. a description of the RAMP required by Section III.D; 8. the following information regarding the IRO(s): (a) the Focus Arrangements Tracking System required by Section III.D.1.aidentity, address, and phone number; (b) a copy of the internal review and approval process required by Section III.D.1.eengagement letter; (c) information to demonstrate that the IRO has the qualifications outlined in Appendix A; and (cd) a certification from the tracking IRO regarding its professional independence and monitoring procedures and other Focus Arrangements Procedures required by Section III.D.1; 11objectivity with respect to Aegerion; 9. a description of the Disclosure Program required by Section III.F; 10. a description of the Ineligible Persons screening and removal process required by Section III.G; 11. a certification by the Compliance Officer that the notice required by Section III.N was posted in the manner required by Section III.N and a summary of the calls or messages received in response to the notice; 12. a certification from the Compliance Officer that the information regarding Payments and the link to CMS’s Open Payments Data website has been posted on Aegerion’s website as required by Section III.O; 13. a list of all of Aegerion’s U.S-based locations (including locations and mailing addresses); the corresponding name under which each location is doing business; and the location’s Medicare and state Medicaid program provider number and/or supplier number(s) (if applicable); 14. a description of or a table depicting Aegerion’s corporate structure, including identification of any parent and sister companies, subsidiaries, and their respective lines of business; and 15. the certifications required by Section V.C.